DEFA14A ·Filed Jun 5, 2026

CDNA

CareDx, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001104659-26-070996
Proxy solicitation materials
Actionable Insight • Neutral

Routine proxy supplement with no new financial information. Monitor the June 11 annual meeting for say-on-pay vote outcome, but no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
CDNA ▲ +32.39% at T+20d
NEUTRAL call ✓ call won +32.39% · α vs SPY +30.76% · entry $21.95 → $29.06
Next anchor: T+60d due 4w ago
Latest observation: T+57 +64.74% FF3 residual α
Entry anchored
Jun 5, 2026
via day open
T+1d
+3.64%
call +3.64% · α +3.94%
$22.75
settled 4mo ago
T+5d
+9.70%
call +9.70% · α +7.59%
$24.08
settled 4mo ago
T+20d
+32.39%
call +32.39% · α +30.76%
$29.06
settled 3mo ago
T+60d
—
call — · α —
—
due 4w ago

Price Chart

Loading chart...

Executive Summary

CareDx filed a DEFA14A supplementing its 2026 proxy statement to clarify the calculation of the 2025 cash bonus program metrics. The supplement provides as-adjusted figures for Adjusted EBITDA ($38.5M, 123% of target) and Cash ($288M, 200% of target), but does not change any previously disclosed bonus payouts or voting matters. This is a routine clarification with no material financial impact.

Key Facts

  • Supplement clarifies 2025 cash bonus program metrics: Revenue $380M (88% of target), Adjusted EBITDA $38.5M (123% of target), Cash $288M (200% of target).
  • Total financial goals achieved at 124% of target.
  • No changes to previously disclosed bonus payouts or voting proposals.
  • Annual meeting scheduled for June 11, 2026.

Financial Impact

No change to previously disclosed bonus amounts; total achievement 124% of target.

revenueadjusted EBITDAcash

Risk Factors

  • None from this filing; routine disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
62% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-070996
Document: 0001104659-26-070996-index-headers.html0001104659-26-070996
Document: 0001104659-26-070996-index.html0001104659-26-070996
Document: 0001104659-26-070996.txt0001104659-26-070996
9 reports for CDNA
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +28.28%Apr 16, 2026
Filters
Rows
Reports for CDNA — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$44.81 $47.38▲ +5.74%▲ +4.52%$66.55 (+48.52%)
Aug 4, 2026
8w ago
144
NEUTRAL ★ 2/10
$45.50 $47.31▲ +3.98%▲ +3.63%$66.55 (+46.26%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 4/10
$39.73 $37.61▼ −5.34%▼ −4.65%$66.55 (+67.51%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $27.13▲ +15.55%▲ +16.59%$66.55 (+183.43%)
Jun 5, 2026
16w ago
DEFA14A
NEUTRAL ★ 2/10
$21.95 $24.08▲ +9.70%▲ +7.59%$66.55 (+203.19%)
Apr 28, 2026
22w ago
S-3ASR
NEUTRAL ★ 5/10
$20.80 $20.70▼ −0.48%▼ −3.59%$66.55 (+219.95%)
Apr 16, 2026
24w ago
8-K
BULLISH ★ 8/10
$22.42 $20.06▼ −10.53%▼ −11.51%$66.55 (+196.83%)
Feb 25, 2026
31w ago
8-K/A
BULLISH ★ 8/10
$18.46 $19.06▲ +3.25%▲ +4.35%$66.55 (+260.51%)
Feb 24, 2026
31w ago
8-K
BULLISH ★ 7/10
$18.46 $19.06▲ +3.25%▲ +4.35%$66.55 (+260.51%)
Showing 9 of 9

US Market Status

Market Open — Closes in 2h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access